Literature DB >> 10682302

Psychiatric symptoms of inherited metabolic disease.

Y Estrov1, F Scaglia, O A Bodamer.   

Abstract

Inborn errors of metabolism often present with a variety of psychiatric symptoms. With improved diagnosis and treatment options, many patients have increased lifespans; consequently, issues of long-term quality of life are coming to the forefront. Mental health concerns are among these issues. To demonstrate the connection between the course of metabolic disease and its psychiatric manifestations, four different inborn errors of metabolism are reviewed: phenylketonuria, Wilson disease, acute intermittent porphyria, and metachromatic leukodystrophy.

Entities:  

Mesh:

Year:  2000        PMID: 10682302     DOI: 10.1023/a:1005685010766

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  26 in total

Review 1.  Porphyria: reexamination of psychiatric implications.

Authors:  K Burgovne; R Swartz; J Ananth
Journal:  Psychother Psychosom       Date:  1995       Impact factor: 17.659

2.  Alzheimer-type pathology in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS).

Authors:  M Kaido; H Fujimura; F Soga; K Toyooka; H Yoshikawa; T Nishimura; T Higashi; K Inui; H Imanishi; S Yorifuji; T Yanagihara
Journal:  Acta Neuropathol       Date:  1996-09       Impact factor: 17.088

3.  Late-onset metachromatic leukodystrophy: diagnostic problems elucidated by a case report.

Authors:  D Seidel; H H Goebel; W Scholz
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

4.  Adult psychosocial outcome in early-treated phenylketonuria.

Authors:  M D Ris; A M Weber; M M Hunt; H K Berry; S E Williams; N Leslie
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

5.  Folate-responsive homocystinuria and "schizophrenia". A defect in methylation due to deficient 5,10-methylenetetrahydrofolate reductase activity.

Authors:  J M Freeman; J D Finkelstein; S H Mudd
Journal:  N Engl J Med       Date:  1975-03-06       Impact factor: 91.245

6.  Psychiatric manifestations of homocystinuria due to cystathionine beta-synthase deficiency: prevalence, natural history, and relationship to neurologic impairment and vitamin B6-responsiveness.

Authors:  M H Abbott; S E Folstein; H Abbey; R E Pyeritz
Journal:  Am J Med Genet       Date:  1987-04

7.  Agoraphobia in phenylketonuria.

Authors:  S E Waisbren; H L Levy
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

8.  Psychosis in an adolescent patient with Wilson's disease: effects of chelation therapy.

Authors:  L V McDonald; C R Lake
Journal:  Psychosom Med       Date:  1995 Mar-Apr       Impact factor: 4.312

9.  Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria. A model for the study of phenylalanine and brain function in man.

Authors:  W Krause; M Halminski; L McDonald; P Dembure; R Salvo; D Freides; L Elsas
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

10.  Neuropsychological aspects of Wilson's disease.

Authors:  J K Rathbun
Journal:  Int J Neurosci       Date:  1996-04       Impact factor: 2.292

View more
  10 in total

1.  Self-rated psychosocial consequences and quality of life in the acute porphyrias.

Authors:  L M Millward; P Kelly; A Deacon; V Senior; T J Peters
Journal:  J Inherit Metab Dis       Date:  2001-12       Impact factor: 4.982

Review 2.  [Demyelinating disorders].

Authors:  T Weber; W Köhler
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

Review 3.  Organic psychosis: Insight into the biology of psychosis.

Authors:  N T Lautenschlager; H Förstl
Journal:  Curr Psychiatry Rep       Date:  2001-08       Impact factor: 5.285

Review 4.  Psychiatric Aspects of Acute Porphyria: a Comprehensive Review.

Authors:  Laura Duque-Serrano; Liliana Patarroyo-Rodriguez; Dorothy Gotlib; Juan C Molano-Eslava
Journal:  Curr Psychiatry Rep       Date:  2018-02-02       Impact factor: 5.285

Review 5.  Psychiatric manifestations revealing inborn errors of metabolism in adolescents and adults.

Authors:  F Sedel; N Baumann; J-C Turpin; O Lyon-Caen; J-M Saudubray; D Cohen
Journal:  J Inherit Metab Dis       Date:  2007-08-10       Impact factor: 4.982

Review 6.  Psychiatric manifestations of treatable hereditary metabolic disorders in adults.

Authors:  Caroline Demily; Frédéric Sedel
Journal:  Ann Gen Psychiatry       Date:  2014-09-24       Impact factor: 3.455

7.  Onset of psychiatric signs and impaired neurocognitive domains in inherited metabolic disorders: A case series.

Authors:  François Medjkane; Marine Bohet; Marielle Ister; David Cohen; Aesa Parenti; Majda Janati; Karine Mention; Dries Dobbelaere; Renaud Jardri
Journal:  JIMD Rep       Date:  2021-02-09

8.  Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia.

Authors:  Mark G A Opler; Alan S Brown; Joseph Graziano; Manisha Desai; Wei Zheng; Catherine Schaefer; Pamela Factor-Litvak; Ezra S Susser
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031

Review 9.  Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review.

Authors:  Olivier Bonnot; Hans Hermann Klünemann; Frederic Sedel; Sylvie Tordjman; David Cohen; Mark Walterfang
Journal:  Orphanet J Rare Dis       Date:  2014-04-28       Impact factor: 4.123

Review 10.  Can psychiatric childhood disorders be due to inborn errors of metabolism?

Authors:  A Simons; F Eyskens; I Glazemakers; D van West
Journal:  Eur Child Adolesc Psychiatry       Date:  2016-09-30       Impact factor: 4.785

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.